Afton Lifescience Ups the Ante: New 8 Crore API Mfg Unit Coming to Gujarat

Afton Lifescience unveils its latest endeavor, an Active Pharmaceutical Ingredients (API) Manufacturing Unit project located in Bamanbor, Surendranagar, Gujarat, with an investment of 8 crores. This state-of-the-art facility is poised to revolutionize the pharmaceutical industry with its cutting-edge technology and innovative processes.

With a production capacity of 110.2 tons per month, Afton Lifescience's API Manufacturing Unit is set to meet the growing demand for high-quality pharmaceutical ingredients. The facility is equipped with advanced machinery and adheres to stringent quality standards, ensuring the production of safe and efficacious APIs.

Situated in Bamanbor, Surendranagar, the project benefits from strategic positioning, offering easy access to key transportation networks and logistical advantages. This prime location enhances efficiency in production and distribution, further bolstering Afton Lifescience's competitive edge in the market.

Afton Lifescience's commitment to excellence and innovation is reflected in the design and operation of its API Manufacturing Unit. With a focus on quality, safety, and environmental sustainability, the project embodies the company's dedication to delivering products that positively impact global healthcare.

News by Rahul Yelligetti